Physician profile
Obinna Orji
NPI 1588920516
$2,160.62
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,571 · 2020: $347 · 2021: $242.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,252.79 | 2019-2021 | |
| Stryker Corporation | $497.87 | 2019 | |
| Boston Scientific Corporation | $127.08 | 2019-2020 | |
| Abbott Laboratories | $75.83 | 2020-2021 | |
| Medtronic USA, INC. | $60.01 | 2020 | |
| Pacira Therapeutics, INC. | $26.21 | 2020 | |
| Medtronic, INC. | $25.60 | 2021 | |
| Biodelivery Sciences International, INC. | $24.52 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $23.07 | 2021 | |
| Abbvie INC. | $19.12 | 2021 | |
| Nalu Medical, INC. | $16.34 | 2021 | |
| Pfizer INC. | $12.18 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Obinna Orji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.